These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4801079)

  • 21. Modification of striatal acetylcholine concentration by dopamine receptor agonists and antagonists.
    Sethy VH; VAN Woert MH
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):13-28. PubMed ID: 4847901
    [No Abstract]   [Full Text] [Related]  

  • 22. The role of brain 5-hydroxytryptamine in the central action of L-DOPA.
    Maj J; Pawlowski L; Sarnek J
    Adv Biochem Psychopharmacol; 1974; 10():253-6. PubMed ID: 4846541
    [No Abstract]   [Full Text] [Related]  

  • 23. Analysis of the aggressiveness-stereotypy complex induced in mice by amphetamine or D,L-dopa. II.
    Roliński Z
    Pol J Pharmacol Pharm; 1974; 26(3):369-78. PubMed ID: 4277363
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of levodopa on the norepinephrine stores in rat heart.
    Liu PL; Krenis LJ; Ngai SH
    Anesthesiology; 1971 Jan; 34(1):4-8. PubMed ID: 5540365
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of dopamine-like drugs on rat striatal adenyl cyclase have implications for CNS dopamine receptor topography.
    Miller R; Horn A; Iversen L; Pinder R
    Nature; 1974 Jul; 250(463):238-41. PubMed ID: 4368645
    [No Abstract]   [Full Text] [Related]  

  • 26. Reversal of alpha-methyltyrosine-induced behavioural depression with dihydroxyphenylalanine and amphetamine.
    Moore KE; Rech RH
    J Pharm Pharmacol; 1967 Jun; 19(6):405-7. PubMed ID: 4382374
    [No Abstract]   [Full Text] [Related]  

  • 27. Dopaminergic nervous transmission in Parkinson's disease.
    Rinne UK; Sonninen V; Riekkinen P; Laaksonen H
    Med Biol; 1974 Jun; 52(3):208-17. PubMed ID: 4371255
    [No Abstract]   [Full Text] [Related]  

  • 28. [10 years of L-DOPA therapy of Parkinson's syndrome].
    Birkmayer W
    Wien Klin Wochenschr; 1971 Apr; 83(13):221-7. PubMed ID: 4254333
    [No Abstract]   [Full Text] [Related]  

  • 29. Proceedings: Effect of acute and chronic treatment with L-dopa on catecholamine turnover.
    Yamanaka Y; Kono S
    Jpn J Pharmacol; 1974; 24(0):s:24. PubMed ID: 4545736
    [No Abstract]   [Full Text] [Related]  

  • 30. Urinary excretion and tissue levels of catecholamines during chronic amphetamine intoxication.
    Lewander T
    Psychopharmacologia; 1968; 13(5):394-407. PubMed ID: 5706269
    [No Abstract]   [Full Text] [Related]  

  • 31. [The influence of diethyldithiocarbamate on cerebral catecholamine, spontaneous activity and L-DOPA hyperactivity].
    Aigner A; Hornykiewicz O; Lisch HJ; Springer A
    Med Pharmacol Exp Int J Exp Med; 1967; 17(6):576-85. PubMed ID: 5631692
    [No Abstract]   [Full Text] [Related]  

  • 32. Time-dependent changes in brain 3 H-norepinephrine disappearance caused by L-DOPA administration.
    Hyyppä MT; Wurtman RJ
    Life Sci I; 1972 Aug; 11(15):713-21. PubMed ID: 4678968
    [No Abstract]   [Full Text] [Related]  

  • 33. 3,4-Dihydroxyphenylalanine (dopa), dopamine and norepinephrine storage in the rat heart after L-dopa--further evidence for norepinephrine release.
    Landsberg L; Bruno SJ
    Biochem Pharmacol; 1973 Feb; 22(3):417-25. PubMed ID: 4687136
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of the locomotor stimulant mechanisms of action of d-amphetamine and d-amphetamine plus l-dopa: possible involvement of serotonin.
    Neuburg J; Thut PD
    Biol Psychiatry; 1974 Apr; 8(2):139-50. PubMed ID: 4276374
    [No Abstract]   [Full Text] [Related]  

  • 35. Amphetamine psychosis: a "model" schizophrenia mediated by catecholamines.
    Snyder SH
    Am J Psychiatry; 1973 Jan; 130(1):61-7. PubMed ID: 4345465
    [No Abstract]   [Full Text] [Related]  

  • 36. L-dopa, dopamine, and hypomania.
    Murphy DL; Goodwin FK; Brodie HK; Bunney WE
    Am J Psychiatry; 1973 Jan; 130(1):79-82. PubMed ID: 4682751
    [No Abstract]   [Full Text] [Related]  

  • 37. Changes in brain norepinephrine associated with sensitization to d-amphetamine.
    Short PH; Shuster L
    Psychopharmacology (Berl); 1976 Jul; 48(1):59-67. PubMed ID: 9657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of L-dopa on behavior and on brain amines in mice treated with 6-hydroxydopamine.
    Barnes L; Cann F; Karczmar AG; Kindel G; Longo VG
    Pharmacol Biochem Behav; 1973; 1(1):35-40. PubMed ID: 4775581
    [No Abstract]   [Full Text] [Related]  

  • 39. Dopamine release and direct dopamine receptor activation in the central nervous system by D-145, an amantadine derivative.
    Svensson TH
    Eur J Pharmacol; 1973 Sep; 23(3):232-8. PubMed ID: 4746740
    [No Abstract]   [Full Text] [Related]  

  • 40. Enhanced sensitivity to noradrenergic agonists and tolerance development to -methyltyrosine in the rat.
    Beuthin FC; Miya TS; Blake DE; Bousquet WF
    J Pharmacol Exp Ther; 1972 Jun; 181(3):446-56. PubMed ID: 5033011
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.